metastatic-recurrent HNSCC (mHNSCC) | ||||
mHNSCC - L1 - all population | mHNSCC - L1 - PDL1 positive | mHNSCC - L2 - all population | mHNSCC - L2 - PDL1 positive | |
anti-PD-(L)1 | ||||
durvalumab based treatment | ||||
durvalumab alone | EAGLE ... | |||
nivolumab based treatment | ||||
nivolumab alone | CheckMate 141 | |||
pembrolizumab based treatment | ||||
pembrolizumab alone | KEYNOTE-048 ... | KEYNOTE-048 ... KEYNOTE-048 ... | KEYNOTE-040 ... | KEYNOTE-040 ... |
pembrolizumab plus 5FU plus platin | KEYNOTE-048 ... | KEYNOTE-048 ... KEYNOTE-048 ... |